The trajectory of Viagra presents a intricate picture for shareholders. While the initial introduction generated massive returns, the expiration of its patent opened the floodgates to off-brand versions, dramatically https://liviadfew175085.jts-blog.com/40387985/sildenafil-and-big-pharma-a-volatile-opportunity